Form 4 Tracker
BIO-TECHNE Corp
TECH

10 insider filings · Latest: Jul 29, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 8, 2026May 12 8:04 PMAmy E. HerrDirector
Sale
6,636$48.28$320.4K200(I)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 29, 2026Jul 31 9:18 PMJames HippelCFO
Option Exercise
62,068$47.600(D)

View →

Jul 28, 2026Jul 30 8:11 PMKim KeldermanDirector, Chief Executive Officer
Option Exercise
35,000$47.600(D)

View →

Jul 23, 2026Jul 27 8:03 PMShane BohnenSVP - General Counsel
Option Exercise
448$47.600(D)

View →

Jun 2, 2026Jun 4 8:28 PMSteven C. CrousePresident - Diag & Spatial Bi
Option Exercise
6001,200(D)

View →

May 8, 2026May 12 8:04 PMAmy E. HerrDirector
Option Exercise
6,636$47.600(I)

View →

May 5, 2026May 7 9:26 PMJames HippelCFO
Option Exercise
62,000$47.6062,068(D)

View →

May 5, 2026May 7 9:24 PMShane BohnenSVP - General Counsel
Option Exercise
8,400$47.60448(D)

View →

May 5, 2026May 7 9:22 PMKim KeldermanDirector, Chief Executive Officer
Option Exercise
26,692$47.6035,000(D)

View →

May 1, 2026May 5 8:12 PMSteven C. CrousePresident - Diag & Spatial Bi
Option Exercise
794794(D)

View →

Mar 2, 2026Mar 4 11:48 PMSteven C. CrousePresident - Diag & Spatial Bi
Grant/Award
5,033$57.821,911(D)

View →